UK:
Milbank Advises Joint Bookrunners On Vivion's €300M Bond Offering
18 November 2019
Milbank LLP
To print this article, all you need is to be registered or login on Mondaq.com.
Milbank LLP advised the joint Bookrunners in connection with the
issuance by Vivion Investments S.à r.l. of €300 million
3.50% Senior Notes due 2025.
Vivion is a commercial real estate company focused on the
ownership, management and improvement of hotels and commercial
office property in the United Kingdom and Germany.
The notes are the second offering of the company and are being
offered to the market three months after the company’s debut
issuance and shortly after the company completed a series of
transformative transactions, including a holding company
reorganization, several acquisitions and a disposal of property, a
separation of property-owning companies from operating companies
and the refinancing of certain indebtedness. The net proceeds will
be used for the acquisition of real estate assets in Germany.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Finance and Banking from UK
Asset Recovery Comparative Guide
Bird & Bird
Asset Recovery Comparative Guide for the jurisdiction of UK, check out our comparative guides section to compare across multiple countries
FCA's Consultation Paper
Cadwalader, Wickersham & Taft LLP
Since 3 January 2018, firms that provide portfolio management or investment advice on an independent basis must pay for the research they obtain...
Regulation Round Up
Proskauer Rose LLP
Welcome to the UK Regulation Round Up, a regular bulletin highlighting the latest developments in UK and EU financial services regulation.
FCA To Permit Research Bundling
Akin Gump Strauss Hauer & Feld LLP
The Financial Conduct Authority (FCA) is seeking views on proposed rules that would allow asset managers to opt for bundled payments for third-party investment research, reversing a significant aspect of the UK's implementation of research rules under the Markets in Financial Instruments Directive (MiFID II).